The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice

Life Sciences

Volumn 87, Issue 19-22, 2010, Pages 643-650

  Nishimura, Sachiyo ^a,c   Ishikura, Hiroyasu ^b   Matsunami, Maho ^a   Shinozaki, Yui ^a   Sekiguchi, Fumiko ^a   Naruse, Mitsuhide ^c   Kitamura, Taisuke ^b   Akashi, Ryukichi ^d   Matsumura, Kenji ^e   Kawabata, Atsufumi ^a  

^a KINKI UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^d Kumamoto City Medical Association   (Japan)

^e Torii Nihonbashi Building   (Japan)

Author keywords

Capsazepine; Pancreatitis; PAR2; Proteinase inhibitor; Transient receptor potential vanilloid 1; Trypsin; Visceral pain

Indexed keywords

AMYLASE; CAPSAZEPINE; CERULETIDE; NAFAMSTAT MESILATE; PROTEIN FOS; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE INHIBITOR; TRYPSIN; VANILLOID RECEPTOR 1;

ACUTE PANCREATITIS; ALLODYNIA; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NOCICEPTION; NONHUMAN; PROPHYLAXIS; REFERRED PAIN; TRANSACTIVATION; VISCERAL PAIN;

ACUTE DISEASE; ANIMALS; CAERULEIN; CAPSAICIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GUANIDINES; HYPERALGESIA; MALE; MICE; OLIGOPEPTIDES; PAIN; PANCREATITIS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, PAR-2; SPINAL CORD; TRPV CATION CHANNELS;

MUS;

EID: 78049437850     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.09.030     Document Type: Article

References (38)

1. Amadesi S., Nie J., Vergnolle N., Cottrell G.S., Grady E.F., Trevisani M., et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004, 24(18):4300-4312.
2. Bunnett N.W. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost 2006, 32(Suppl 1):39-48.
3. Cervero F., Laird J.M. Understanding the signaling and transmission of visceral nociceptive events. J Neurobiol 2004, 61(1):45-54.
4. Coelho A.M., Vergnolle N., Guiard B., Fioramonti J., Bueno L. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002, 122(4):1035-1047.
5. Dai Y., Moriyama T., Higashi T., Togashi K., Kobayashi K., Yamanaka H., et al. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004, 24(18):4293-4299.
6. Dai Y., Wang S., Tominaga M., Yamamoto S., Fukuoka T., Higashi T., et al. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Investig 2007, 117(7):1979-1987.
7. Fasanella K.E., Christianson J.A., Chanthaphavong R.S., Davis B.M. Distribution and neurochemical identification of pancreatic afferents in the mouse. J Comp Neurol 2008, 509(1):42-52.
8. Grant A.D., Cottrell G.S., Amadesi S., Trevisani M., Nicoletti P., Materazzi S., et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol 2007, 578(Pt 3):715-733.
9. Hoogerwerf W.A., Zou L., Shenoy M., Sun D., Micci M.A., Lee-Hellmich H., et al. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 2001, 21(22):9036-9042.
10. Hoogerwerf W.A., Shenoy M., Winston J.H., Xiao S.Y., He Z., Pasricha P.J. Trypsin mediates nociception via the proteinase-activated receptor 2: a potentially novel role in pancreatic pain. Gastroenterology 2004, 127(3):883-891.
11. Hutter M.M., Wick E.C., Day A.L., Maa J., Zerega E.C., Richmond A.C., et al. Transient receptor potential vanilloid (TRPV-1) promotes neurogenic inflammation in the pancreas via activation of the neurokinin-1 receptor (NK-1R). Pancreas 2005, 30(3):260-265.
12. Ishikura H., Nishimura S., Matsunami M., Tsujiuchi T., Ishiki T., Sekiguchi F., et al. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents. Life Sci 2007, 80(21):1999-2004.
13. Kawabata A., Kawao N., Kuroda R., Tanaka A., Itoh H., Nishikawa H. Peripheral PAR-2 triggers thermal hyperalgesia and nociceptive responses in rats. NeuroReport 2001, 12(4):715-719.
14. Kawabata A., Kinoshita M., Kuroda R., Kakehi K. Capsazepine partially inhibits neurally mediated gastric mucus secretion following activation of protease-activated receptor 2. Clin Exp Pharmacol Physiol 2002, 29(4):360-361.
15. Kawabata A., Kanke T., Yonezawa D., Ishiki T., Saka M., Kabeya M., et al. Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo. J Pharmacol Exp Ther 2004, 309(3):1098-1107.
16. Kawabata A., Matsunami M., Tsutsumi M., Ishiki T., Fukushima O., Sekiguchi F., et al. Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice. Br J Pharmacol 2006, 148(1):54-60.
17. Kawabata A., Matsunami M., Sekiguchi F. Gastrointestinal roles for proteinase-activated receptors in health and disease. Br J Pharmacol 2008, 153(Suppl 1):S230-S240.
18. Kawao N., Shimada C., Itoh H., Kuroda R., Kawabata A. Capsazepine inhibits thermal hyperalgesia but not nociception triggered by protease-activated receptor-2 in rats. Japanses J Pharmacol 2002, 89(2):184-187.
19. Kawao N., Ikeda H., Kitano T., Kuroda R., Sekiguchi F., Kataoka K., et al. Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2. J Pharmacol Sci 2004, 94(3):277-285.
20. Laukkarinen J.M., Weiss E.R., van Acker G.J., Steer M.L., Perides G. Protease-activated receptor-2 exerts contrasting model-specific effects on acute experimental pancreatitis. J Biol Chem 2008, 283(30):20703-20712.
21. Lee J.K., Ryu J.K., Park J.K., Lee S.H., Yoon W.J., Kim Y.T., et al. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis. Pancreas 2008, 36(3):255-260.
22. Liddle R.A. The role of Transient Receptor Potential Vanilloid 1 (TRPV1) channels in pancreatitis. Biochim Biophys Acta 2007, 1772(8):869-878.
23. Maeda K., Hirota M., Kimura Y., Ichihara A., Ohmuraya M., Sugita H., et al. Proinflammatory role of trypsin and protease-activated receptor-2 in a rat model of acute pancreatitis. Pancreas 2005, 31(1):54-62.
24. Manabe T., Hirano T., Imanishi K., Ando K., Yotsumoto F., Tobe T. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis. Int J Pancreatol 1992, 12(2):167-172.
25. Matej R., Housa D., Olejar T. Acute pancreatitis: proteinase-activated receptor-2 as Dr. Jekyll and Mr. Hyde. Physiol Res 2006, 55(5):467-474.
26. Namkung W., Han W., Luo X., Muallem S., Cho K.H., Kim K.H., et al. Protease-activated receptor 2 exerts local protection and mediates some systemic complications in acute pancreatitis. Gastroenterology 2004, 126(7):1844-1859.
27. Nathan J.D., Patel A.A., McVey D.C., Thomas J.E., Prpic V., Vigna S.R., et al. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 2001, 281(5):G1322-G1328.
28. Nishimura S., Fukushima O., Ishikura H., Takahashi T., Matsunami M., Tsujiuchi T., et al. Hydrogen sulfide as a novel mediator for pancreatic pain in rodents. Gut 2009, 58(6):762-770.
29. Oikonomopoulou K., Hansen K.K., Saifeddine M., Vergnolle N., Tea I., Diamandis E.P., et al. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more. Biol Chem 2006, 387(6):677-685.
30. Romac J.M., McCall S.J., Humphrey J.E., Heo J., Liddle R.A. Pharmacologic disruption of TRPV1-expressing primary sensory neurons but not genetic deletion of TRPV1 protects mice against pancreatitis. Pancreas 2008, 36(4):394-401.
31. Sharma A., Tao X., Gopal A., Ligon B., Andrade-Gordon P., Steer M.L., et al. Protection against acute pancreatitis by activation of protease-activated receptor-2. Am J Physiol Gastrointest Liver Physiol 2005, 288(2):G388-G395.
32. Singh V.P., Bhagat L., Navina S., Sharif R., Dawra R.K., Saluja A.K. Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion. Gut 2007, 56(7):958-964.
33. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., Ennes H.S., et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000, 6(2):151-158.
34. Stucky C.L., Dubin A.E., Jeske N.A., Malin S.A., McKemy D.D., Story G.M. Roles of transient receptor potential channels in pain. Brain Res Rev 2009, 60(1):2-23.
35. Takeda K., Matsuno S., Sunamura M., Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg 1996, 171(4):394-398.
36. Vergnolle N., Bunnett N.W., Sharkey K.A., Brussee V., Compton S.J., Grady E.F., et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 2001, 7(7):821-826.
37. Wick E.C., Hoge S.G., Grahn S.W., Kim E., Divino L.A., Grady E.F., et al. Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2006, 290(5):G959-G969.
38. Xu G.Y., Winston J.H., Shenoy M., Yin H., Pendyala S., Pasricha P.J. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis. Gastroenterology 2007, 133(4):1282-1292.